Home
Xanomeline-Trospium (KarXT) Shows Efficacy in Phase 3 Trial for Schizophrenia
Psychopharmacology Institute
Jun 10, 2024
1,898 views
Treating Schizophrenia with Muscarinic Antipsychotics | Steve Paul
KarXT for Schizophrenia: Mechanism of Action?
Exploring Successful Benzodiazepine Tapering Techniques
KarXT (xanomeline-trospium) for Schizophrenia: Long-Term Efficacy & Next Steps, with Rishi Kakar, MD
Why would an acetylcholine agonist make psychosis better?
The Myth of Low-Serotonin & Antidepressants - Dr. Mark Horowitz
Medication Used to Treat Schizophrenia and Their Side Effects | with Pharmacist Matthew Elswood
Real-Time PCR in Action
Decoding the Brain
Vitamin D, now conclusive
Kisunla for Alzheimer’s, Sirturo for TB, Kar-XT for Schizophrenia, MDMA-based Therapy for...
Abilify
How an common anti-fungal drug could help stop brain disease
Muscarinic Cholinergic M1/M4 Stimulation: Muscarinic Agents for SCZ Treatment
Medications for Schizophrenia: Therapies - Psychiatric Mental Health | @LevelUpRN
The Devastating Reality of Methamphetamine Psychosis: A Warning
Avatar therapy for schizophrenia
Second-Generation Antipsychotics for Bipolar Mania With Mixed Features
What's it like to live with #schizophrenia?
New and Novel Schizophrenia Treatment Paradigms: Moving Beyond Post-Synaptic Dopamine Modulation